Risk of Birth Complications Doubles After Assisted Conception

Published January 13, 2014

Risk of birth complications doubles after assisted conception
They compared the risks of in-vitro fertilisation (IVF), which treats female fertility, intracytoplasmic sperm injection (ICSI) for male infertility, and ovulation induction, where women take the drug clomiphene citrate to maximise the chance of … Read more on The Conversation

Mild Electronic Stimulation Therapy Effective For Sleep Apnea, Study Finds
A new study published today in the New England Journal of Medicine detailed the results of a phase III trial testing the safety and efficacy of mild electronic stimulation therapy for treating obstructive sleep apnea. The trial showed that the … Read more on Huffington Post

Don't litter
A recent study—Cost-control Mechanisms in Canadian Private Drug Plans, conducted by the University of British Columbia and McGill University—found that more than 16% of employees now have annual or lifetime maximum drug coverage limits on their plans … Read more on Benefits Canada

Synta Pharmaceuticals Corp. : Synta Announces Initiation of Three Multicenter …
Ganetespib, Synta's lead anti-cancer drug candidate, inhibits the heat shock protein 90 (Hsp90) chaperone protein and is being studied in over 25 clinical trials, including an ongoing Phase 3 trial in advanced non-small cell lung cancer. The biologic … Read more on 4-traders (press release)